Literature DB >> 30726573

Emerging links between pediatric lysosomal storage diseases and adult parkinsonism.

Daniel Ysselstein1, Joshua M Shulman2,3, Dimitri Krainc1.   

Abstract

Lysosomal storage disorders comprise a clinically heterogeneous group of autosomal-recessive or X-linked genetic syndromes caused by disruption of lysosomal biogenesis or function resulting in accumulation of nondegraded substrates. Although lysosomal storage disorders are diagnosed predominantly in children, many show variable expressivity with clinical presentations possible later in life. Given the important role of lysosomes in neuronal homeostasis, neurological manifestations, including movement disorders, can accompany many lysosomal storage disorders. Over the last decade, evidence from genetics, clinical epidemiology, cell biology, and biochemistry have converged to implicate links between lysosomal storage disorders and adult-onset movement disorders. The strongest evidence comes from mutations in Glucocerebrosidase, which cause Gaucher's disease and are among the most common and potent risk factors for PD. However, recently, many additional lysosomal storage disorder genes have been similarly implicated, including SMPD1, ATP13A2, GALC, and others. Examination of these links can offer insight into pathogenesis of PD and guide development of new therapeutic strategies. We systematically review the emerging genetic links between lysosomal storage disorders and PD.
© 2019 International Parkinson and Movement Disorder Society. © 2019 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Parkinson's disease; genetics; lysosomal storage disease; movement disorders

Mesh:

Substances:

Year:  2019        PMID: 30726573      PMCID: PMC6520126          DOI: 10.1002/mds.27631

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  123 in total

1.  Myelin pathology in the twitcher mouse.

Authors:  K Suzuki; K Suzuki
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

2.  Perspective: Finding common ground.

Authors:  Anthony H Futerman; John Hardy
Journal:  Nature       Date:  2016-09-22       Impact factor: 49.962

3.  ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity.

Authors:  Idit Ron; Mia Horowitz
Journal:  Hum Mol Genet       Date:  2005-07-06       Impact factor: 6.150

4.  Lack of association between ATP13A2 Ala746Thr variant and Parkinson's disease in Han population of mainland China.

Authors:  Qing-Zhou Fei; Li Cao; Qin Xiao; Ting Zhang; Lan Zheng; Xi-Jin Wang; Gang Wang; Hai-Yan Zhou; Ying Wang; Sheng-Di Chen
Journal:  Neurosci Lett       Date:  2010-03-19       Impact factor: 3.046

5.  Accumulation of glycosphingolipids in Niemann-Pick C disease disrupts endosomal transport.

Authors:  Danielle te Vruchte; Emyr Lloyd-Evans; Robert Jan Veldman; David C A Neville; Raymond A Dwek; Frances M Platt; Wim J van Blitterswijk; Dan J Sillence
Journal:  J Biol Chem       Date:  2004-04-12       Impact factor: 5.157

Review 6.  Mechanisms and consequences of impaired lipid trafficking in Niemann-Pick type C1-deficient mammalian cells.

Authors:  Barbara Karten; Kyle B Peake; Jean E Vance
Journal:  Biochim Biophys Acta       Date:  2009-02-11

7.  Genetic and pathological links between Parkinson's disease and the lysosomal disorder Sanfilippo syndrome.

Authors:  Sophie E Winder-Rhodes; Pablo Garcia-Reitböck; Maria Ban; Jonathan R Evans; Thomas S Jacques; Anu Kemppinen; Thomas Foltynie; Caroline H Williams-Gray; Patrick F Chinnery; Gavin Hudson; David J Burn; Liesl M Allcock; Stephen J Sawcer; Roger A Barker; Maria Grazia Spillantini
Journal:  Mov Disord       Date:  2011-11-18       Impact factor: 10.338

8.  Identification and characterization of 15 novel GALC gene mutations causing Krabbe disease.

Authors:  Barbara Tappino; Roberta Biancheri; Matthew Mort; Stefano Regis; Fabio Corsolini; Andrea Rossi; Marina Stroppiano; Susanna Lualdi; Agata Fiumara; Bruno Bembi; Maja Di Rocco; David N Cooper; Mirella Filocamo
Journal:  Hum Mutat       Date:  2010-12       Impact factor: 4.878

9.  Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's.

Authors:  Ganqiang Liu; Brendon Boot; Joseph J Locascio; Iris E Jansen; Sophie Winder-Rhodes; Shirley Eberly; Alexis Elbaz; Alexis Brice; Bernard Ravina; Jacobus J van Hilten; Florence Cormier-Dequaire; Jean-Christophe Corvol; Roger A Barker; Peter Heutink; Johan Marinus; Caroline H Williams-Gray; Clemens R Scherzer
Journal:  Ann Neurol       Date:  2016-11       Impact factor: 10.422

Review 10.  Targeted Therapies for Parkinson's Disease: From Genetics to the Clinic.

Authors:  S Pablo Sardi; Jesse M Cedarbaum; Patrik Brundin
Journal:  Mov Disord       Date:  2018-04-27       Impact factor: 10.338

View more
  15 in total

Review 1.  Emerging and converging molecular mechanisms in dystonia.

Authors:  Paulina Gonzalez-Latapi; Nicolas Marotta; Niccolò E Mencacci
Journal:  J Neural Transm (Vienna)       Date:  2021-01-01       Impact factor: 3.575

2.  Bi-allelic VPS16 variants limit HOPS/CORVET levels and cause a mucopolysaccharidosis-like disease.

Authors:  Kalliopi Sofou; Kolja Meier; Leslie E Sanderson; Debora Kaminski; Laia Montoliu-Gaya; Emma Samuelsson; Maria Blomqvist; Lotta Agholme; Jutta Gärtner; Chris Mühlhausen; Niklas Darin; Tahsin Stefan Barakat; Lars Schlotawa; Tjakko van Ham; Jorge Asin Cayuela; Fredrik H Sterky
Journal:  EMBO Mol Med       Date:  2021-05-03       Impact factor: 14.260

3.  Murine Models of Lysosomal Storage Diseases Exhibit Differences in Brain Protein Aggregation and Neuroinflammation.

Authors:  Jennifer Clarke; Can Kayatekin; Catherine Viel; Lamya Shihabuddin; Sergio Pablo Sardi
Journal:  Biomedicines       Date:  2021-04-21

Review 4.  GBA, Gaucher Disease, and Parkinson's Disease: From Genetic to Clinic to New Therapeutic Approaches.

Authors:  Giulietta M Riboldi; Alessio B Di Fonzo
Journal:  Cells       Date:  2019-04-19       Impact factor: 6.600

5.  LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson's disease patients.

Authors:  Daniel Ysselstein; Maria Nguyen; Tiffany J Young; Alex Severino; Michael Schwake; Kalpana Merchant; Dimitri Krainc
Journal:  Nat Commun       Date:  2019-12-05       Impact factor: 14.919

Review 6.  Advances in Sphingolipidoses: CRISPR-Cas9 Editing as an Option for Modelling and Therapy.

Authors:  Renato Santos; Olga Amaral
Journal:  Int J Mol Sci       Date:  2019-11-24       Impact factor: 5.923

Review 7.  Sphingolipids as prognostic biomarkers of neurodegeneration, neuroinflammation, and psychiatric diseases and their emerging role in lipidomic investigation methods.

Authors:  Daan van Kruining; Qian Luo; Gerhild van Echten-Deckert; Michelle M Mielke; Andrew Bowman; Shane Ellis; Tiago Gil Oliveira; Pilar Martinez-Martinez
Journal:  Adv Drug Deliv Rev       Date:  2020-04-28       Impact factor: 15.470

8.  Retromer subunit, VPS29, regulates synaptic transmission and is required for endolysosomal function in the aging brain.

Authors:  Hui Ye; Shamsideen A Ojelade; David Li-Kroeger; Zhongyuan Zuo; Liping Wang; Yarong Li; Jessica Yj Gu; Ulrich Tepass; Avital Adah Rodal; Hugo J Bellen; Joshua M Shulman
Journal:  Elife       Date:  2020-04-14       Impact factor: 8.140

Review 9.  Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson's disease in the precision medicine era.

Authors:  Dunhui Li; Frank L Mastaglia; Sue Fletcher; Steve D Wilton
Journal:  Med Res Rev       Date:  2020-08-06       Impact factor: 12.944

10.  Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia.

Authors:  Cornelis Blauwendraat; Xylena Reed; Lynne Krohn; Karl Heilbron; Sara Bandres-Ciga; Manuela Tan; J Raphael Gibbs; Dena G Hernandez; Ravindran Kumaran; Rebekah Langston; Luis Bonet-Ponce; Roy N Alcalay; Sharon Hassin-Baer; Lior Greenbaum; Hirotaka Iwaki; Hampton L Leonard; Francis P Grenn; Jennifer A Ruskey; Marya Sabir; Sarah Ahmed; Mary B Makarious; Lasse Pihlstrøm; Mathias Toft; Jacobus J van Hilten; Johan Marinus; Claudia Schulte; Kathrin Brockmann; Manu Sharma; Ari Siitonen; Kari Majamaa; Johanna Eerola-Rautio; Pentti J Tienari; Alexander Pantelyat; Argye E Hillis; Ted M Dawson; Liana S Rosenthal; Marilyn S Albert; Susan M Resnick; Luigi Ferrucci; Christopher M Morris; Olga Pletnikova; Juan Troncoso; Donald Grosset; Suzanne Lesage; Jean-Christophe Corvol; Alexis Brice; Alastair J Noyce; Eliezer Masliah; Nick Wood; John Hardy; Lisa M Shulman; Joseph Jankovic; Joshua M Shulman; Peter Heutink; Thomas Gasser; Paul Cannon; Sonja W Scholz; Huw Morris; Mark R Cookson; Mike A Nalls; Ziv Gan-Or; Andrew B Singleton
Journal:  Brain       Date:  2020-01-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.